Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 4,654 shares at $1.46 ($7K) on 2022-08-02, disclosed to the SEC on 2022-08-03.
Seasonal sale ($7k) by See Remarks — this insider has traded CLVS in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.46 | 2,100 | $3K | 45.1% |
| 2 | $1.46 | 2,554 | $4K | 54.9% |
| Total | $1.46 avg | 4,654 | $7K | 100% |
| Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |
| CLVS | SELL | 2022-03-03 | $20K | — | Filing → |